BLBP Is Both a Marker for Poor Prognosis and a Potential Therapeutic Target in Paediatric Ependymoma

SIMPLE SUMMARY: Ependymomas are the second most common paediatric brain tumour, and the 5-year survival rate remains no higher than 50%. Identifying new prognostic markers and targets for therapy in ependymoma is an important area of research. In this study, we demonstrate that brain lipid binding p...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabnis, Durgagauri H., Liu, Jo-Fen, Simmonds, Lucy, Blackburn, Sophie, Grundy, Richard G., Kerr, Ian D., Coyle, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123630/
https://www.ncbi.nlm.nih.gov/pubmed/33925302
http://dx.doi.org/10.3390/cancers13092100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123630/
https://www.ncbi.nlm.nih.gov/pubmed/33925302
http://dx.doi.org/10.3390/cancers13092100

Ejemplares similares